These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 7183)

  • 1. Central noradrenergic control of blood pressure.
    Scriabine A; Clineschmidt BV; Sweet CS
    Annu Rev Pharmacol Toxicol; 1976; 16():113-23. PubMed ID: 7183
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of chronic desipramine treatment on rat brain noradrenergic responses to alpha-adrenergic drugs.
    McMillen BA; Warnack W; German DC; Shore PA
    Eur J Pharmacol; 1980 Feb; 61(3):239-46. PubMed ID: 6102522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central adrenoreceptors and the control of arterial blood pressure.
    Day MD; Roach AG
    Clin Exp Pharmacol Physiol; 1974; 1(4):347-60. PubMed ID: 4156506
    [No Abstract]   [Full Text] [Related]  

  • 4. Central and peripheral autonomic mechanisms involved in the circulatory actions of methyldopa.
    Korner PI; Head GA; Bobik A; Badoer E; Aberdeen JA
    Hypertension; 1984; 6(5 Pt 2):II63-70. PubMed ID: 6437977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of noradrenergic and serotonergic neurons to the circulatory effects of centrally acting clonidine and alpha-methyldopa in rabbits.
    Head GA; Korner PI; Lewis SL; Badoer E
    J Cardiovasc Pharmacol; 1983; 5(6):945-53. PubMed ID: 6196566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An antidepressant mechanism of desipramine is to decrease tumor necrosis factor-alpha production culminating in increases in noradrenergic neurotransmission.
    Reynolds JL; Ignatowski TA; Sud R; Spengler RN
    Neuroscience; 2005; 133(2):519-31. PubMed ID: 15878644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of alpha-sympathomimetic agents in the central nervous system. Study of the central effects of adrenergic drugs by injection into the vertebral artery].
    Van Zwieten PA
    Therapie; 1972; 27(4):565-75. PubMed ID: 4404301
    [No Abstract]   [Full Text] [Related]  

  • 8. The interaction between clonidine and desmethylimipramine: effects on blood pressure and central catecholamine metabolism [proceedings].
    Draper AJ; Grimes D; Redfern PH
    J Pharm Pharmacol; 1976 Dec; 28 Suppl():34P. PubMed ID: 12309
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence for a central alpha-sympathomimetic action of clonidine in the rat.
    Finch L; Buckingham RE; Moore RA; Bucher TJ
    J Pharm Pharmacol; 1975 Mar; 27(3):181-6. PubMed ID: 238001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and chronic effects of desipramine and clorgyline on alpha(2)-adrenoceptors regulating noradrenergic transmission in the rat brain: a dual-probe microdialysis study.
    Mateo Y; Fernández-Pastor B; Meana JJ
    Br J Pharmacol; 2001 Aug; 133(8):1362-70. PubMed ID: 11498523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of long-term desipramine administration on noradrenergic neurotransmission: electrophysiological studies in the rat brain.
    Lacroix D; Blier P; Curet O; de Montigny C
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1081-90. PubMed ID: 1646320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central alpha-adrenergic systems as targets for hypotensive drugs.
    Kobinger
    Rev Physiol Biochem Pharmacol; 1978; 81():39-100. PubMed ID: 25484
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacological analysis of the role of central alpha-2 adrenergic and imidazoline receptors in mechanism of the hypotensive effect of clonidine in rats].
    Kuz'min AI; Lodygin DN; Kalenikova EI; Bychkova EIu; Khokhlova ON; Murashev AN; Medvedev OS
    Eksp Klin Farmakol; 2000; 63(4):24-8. PubMed ID: 11022301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoreceptor-mediated inhibition of norepinephrine release in rat medial prefrontal cortex is maintained after chronic desipramine treatment.
    Garcia AS; Barrera G; Burke TF; Ma S; Hensler JG; Morilak DA
    J Neurochem; 2004 Nov; 91(3):683-93. PubMed ID: 15485498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex.
    Devoto P; Flore G; Pira L; Longu G; Gessa GL
    Eur J Pharmacol; 2004 Mar; 487(1-3):105-11. PubMed ID: 15033381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential blood pressure responses to intracisternal clonidine, alpha-methyldopa, and 6-hydroxydopamine in conscious normotensive and spontaneously hypertensive rats.
    Head GA; de Jong W
    J Cardiovasc Pharmacol; 1986; 8(4):735-42. PubMed ID: 2427812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the function of central catecholamine neurons--their role in cardiovascular and arousal mechanisms.
    Bolme P; Fuxe K; Lidbrink P
    Res Commun Chem Pathol Pharmacol; 1972 Nov; 4(3):657-97. PubMed ID: 4404753
    [No Abstract]   [Full Text] [Related]  

  • 18. Proceedings: Relationship between activity and structure in derivative of clonidine.
    Walland A; Hoefke W
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R104. PubMed ID: 4152372
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of alpha-adrenoceptor antagonists administered intraventricularly on central hypotensive action of clonidine and on central hypertensive action of methoxamine in rabbits.
    Kim YI; Paik YH; Kang SS; Kim JH
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):66-76. PubMed ID: 6126161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noradrenergic agonists and antagonists influence migration of cortical spreading depression in rat-a possible mechanism of migraine prophylaxis and prevention of postischemic neuronal damage.
    Richter F; Mikulik O; Ebersberger A; Schaible HG
    J Cereb Blood Flow Metab; 2005 Sep; 25(9):1225-35. PubMed ID: 15829916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.